Virus-specific factors associated with zoonotic and pandemic potential

被引:14
|
作者
Romero-Tejeda, Aurora [1 ]
Capua, Ilaria [1 ]
机构
[1] Ist Zooprofilatt Sperimentale Venezie, Div Comparat Biomed Sci, I-35020 Legnaro, PD, Italy
关键词
Host range; influenza; interspecies transmission; pandemic; virus adaptation; INFLUENZA-A VIRUS; PATHOGENIC AVIAN INFLUENZA; RESPIRATORY EPITHELIAL-CELLS; HUMAN RECEPTOR SPECIFICITY; COMPLETE GENOME SEQUENCE; SIALIC-ACID RECEPTOR; H1N1; 2009; VIRUS; H5N1; VIRUSES; HUMAN INFECTION; HOST-RANGE;
D O I
10.1111/irv.12075
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Influenza A is a highly contagious respiratory virus in constant evolution and represents a threat to both veterinary and human public health. IA viruses (IAVs) originate in avian reservoirs but may adapt to humans, either directly or through the spillover to another mammalian species, to the point of becoming pandemic. IAVs must successfully be able to (i) transmit from animal to human, (ii) interact with host cells, and (iii) transmit from human to human. The mechanisms by which viruses evolve, cause zoonotic infections, and adapt to a new host species are indeed complex and appear to be a heterogeneous collection of viral evolutionary events rather than a single phenomenon. Progress has been made in identifying some of the genetic markers mainly associated with virulence and transmission; this achievement has improved our knowledge of how to manage a pandemic event and of how to identify IAVs with pandemic potential. Early evidence of emerging viruses and surveillance of animal IAVs is made possible only by strengthening the collaboration between the public and veterinary health sectors.
引用
收藏
页码:4 / 14
页数:11
相关论文
共 50 条
  • [11] Monitoring of virus-specific T-cells with virus specific tetramers - implication for virus-specific T-cell therapy?
    Borchers, S.
    Grabow, B.
    Luther, S.
    Heuer, M.
    Ganser, A.
    Weissinger, E. M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S167 - S167
  • [12] Polyomavirus-associated nephropathy: update on BK virus-specific immunity
    Comoli, P.
    Binggeli, S.
    Ginevri, F.
    Hirsch, H. H.
    TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (02) : 86 - 94
  • [14] Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis
    Chen, Zhaochun
    Sosnovtsev, Stanislav V.
    Bok, Karin
    Parra, Gabriel I.
    Makiya, Michelle
    Agulto, Liane
    Green, Kim Y.
    Purcell, Robert H.
    JOURNAL OF VIROLOGY, 2013, 87 (17) : 9547 - 9557
  • [15] ENCEPHALOMYOCARDITIS VIRUS - A POTENTIAL ZOONOTIC PATHOGEN
    LITTLEJOHNS, IR
    ACLAND, HM
    MEDICAL JOURNAL OF AUSTRALIA, 1970, 2 (02) : 101 - +
  • [16] VIRUS-SPECIFIC PROTEINS ASSOCIATED WITH RIBOSOMES OF KREBS-II CELLS INFECTED WITH ENCEPHALOMYOCARDITIS VIRUS
    MEDVEDKINA, OA
    SCARLAT, IV
    KALININA, NO
    AGOL, VI
    FEBS LETTERS, 1974, 39 (01) : 4 - 8
  • [17] VIRUS-SPECIFIC FACTORS IN EXPERIMENTAL ARGENTINE HEMORRHAGIC-FEVER IN RHESUS MACAQUES
    MCKEE, KT
    MAHLANDT, BG
    MAIZTEGUI, JI
    GREEN, DE
    PETERS, CJ
    JOURNAL OF MEDICAL VIROLOGY, 1987, 22 (02) : 99 - 111
  • [18] Skewed maturation of virus-specific CTLs?
    Laila E. Gamadia
    Ineke J. M. Ten Berge
    Louis J. Picker
    René A.W. van Lier
    Nature Immunology, 2002, 3 : 203 - 203
  • [19] Induction of virus-specific immunity by iscoms
    Osterhaus, ADME
    Rimmelzwaan, GF
    MODULATION OF THE IMMUNE RESPONSE TO VACCINE ANTIGENS, 1998, 92 : 49 - 58
  • [20] VirOligo: a database of virus-specific oligonucleotides
    Onodera, K
    Melcher, U
    NUCLEIC ACIDS RESEARCH, 2002, 30 (01) : 203 - 204